Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
<i>Background</i>. Monoclonal antibodies (mAbs) directed against the calcitonin gene-related peptide (CGRP) or its receptor represented the first targeted and specialized approach to migraine prophylaxis. Nevertheless, they have been rarely considered in the treatment of vestibular migraine (VM). Ou...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2023-08-01
|
| Schriftenreihe: | Medicina |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1648-9144/59/9/1560 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|